Cargando…
Natural HDAC‐1/8 inhibitor baicalein exerts therapeutic effect in CBF‐AML
BACKGROUND: Although targeting histone deacetylases (HDACs) may be an effective strategy for core binding factor‐acute myeloid leukemia (CBF‐AML) harboring t(8;21) or inv(16), HDAC inhibitors are reported to be limited by drug‐resistant characteristic. Our purpose is to evaluate the anti‐leukemia ef...
Autores principales: | Yu, Xiaoxuan, Li, Hui, Hu, Po, Qing, Yingjie, Wang, Xiangyuan, Zhu, Mengyuan, Wang, Hongzheng, Wang, Zhanyu, Xu, Jingyan, Guo, Qinglong, Hui, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449246/ https://www.ncbi.nlm.nih.gov/pubmed/32898337 http://dx.doi.org/10.1002/ctm2.154 |
Ejemplares similares
-
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
por: Qing, Yingjie, et al.
Publicado: (2021) -
One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence
por: Qing, Yingjie, et al.
Publicado: (2021) -
Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218
por: Hu, Po, et al.
Publicado: (2021) -
Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies
por: Qing, Yingjie, et al.
Publicado: (2023) -
FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation
por: Hu, Po, et al.
Publicado: (2021)